Cite

HARVARD Citation

    Gogebakan, K. et al. (2021). Impact of novel systemic therapies on the first‐year costs of care for melanoma among Medicare beneficiaries. Cancer. 127 (16), pp. 2926-2933. [Online]. 
  
Back to record